ALVR Kalaris Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $6.18M and sold $12.9K on the open market.
Recent ALVR insider trades
- May 20, 2026: Akkaraju Srinivas bought 244,300 shares ($1.18M)
- Mar 20, 2026: Hagen Brett R sold 1,915 shares ($12.9K)
- Dec 18, 2025: Akkaraju Srinivas bought 479,847 shares ($5.00M)
- Mar 26, 2025: Hagen Brett R sold 907 shares ($8.14K)
5%+ owners
- Samsara BioCapital, L.P.: 61.2% (Schedule 13D, filed Mar 25, 2025)
- Srinivas Akkaraju: 54.2% (Schedule 13D/A, filed May 22, 2026)
- RTW Investments, LP: 5.7% (Schedule 13G, filed Feb 17, 2026)